Pharmacologic treatment of acute major depression and dysthymia

被引：95

作者：

Snow, V ^{[1
]}

Lascher, S ^{[1
]}

Mottur-Pilson, C ^{[1
]}

机构：

[1] Amer Coll Physicians, Amer Soc Internal Med, Educ Div, Sci Policy Dept,Customer Serv, Philadelphia, PA 19106 USA

来源：

ANNALS OF INTERNAL MEDICINE | 2000年 / 132卷 / 09期

关键词：

D O I：

10.7326/0003-4819-132-9-200005020-00010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This guideline answers the following questions: What evidence supports the benefits of pharmacologic treatment of depression? What are the data on the efficacy and side effects of newer compared with older pharmacotherapies? How can the evidence assist physicians and patients in making informed decisions about treatment options?

引用

页码：738 / 742

页数：5

共 6 条

[1]

Depression Guideline Panel, 1993, AHCPR PUBL, V2

[2] Treating depression as a recurrent or chronic disease [J].

Glass, RM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (01) :83-84

[3]

Medical Economics, 1998, MED EC

[4]

MULROW CD, 1999, AHCPR PUBLICATION

[5] Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression - A randomized controlled trial in patients older than 59 years [J].

Reynolds, CF ;

Frank, E ;

Perel, JM ;

Imber, SD ;

Cornes, C ;

Miller, MD ;

Mazumdar, S ;

Houck, PR ;

Dew, MA ;

Stack, JA ;

Pollock, BG ;

Kupfer, DJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (01) :39-45

[6] Initial antidepressant choice in primary care - Effectiveness and cost of fluoxetine vs tricyclic antidepressants [J].

Simon, GE ;

VonKorff, M ;

Heiligenstein, JH ;

Revicki, DA ;

Grothaus, L ;

Katon, W ;

Wagner, EH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (24) :1897-1902

← 1 →